Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD

BACKGROUND AND OBJECTIVES: Epidemiologic studies suggest that higher serum phosphaturic hormone fibroblast growth factor 23 levels are associated with increase morbidity and mortality. The aim of the FGF23 Reduction Efficacy of a New Phosphate Binder in CKD Trial was to evaluate the effect of sevela...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin J Am Soc Nephrol
Main Authors: Liabeuf, Sophie, Ryckelynck, Jean-Philippe, El Esper, Najeh, Ureña, Pablo, Combe, Christian, Dussol, Bertrand, Fouque, Denis, Vanhille, Philippe, Frimat, Luc, Thervet, Eric, Mentaverri, Romuald, Prié, Dominique, Choukroun, Gabriel
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718266/
https://ncbi.nlm.nih.gov/pubmed/29074818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03030317
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados